Quality statement 10: Access to radiotherapy

Quality statement

People with lung cancer are assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

Quality measure

Structure: Evidence of local arrangements and written clinical protocols to ensure that people with lung cancer are assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

Process: Proportion of people with lung cancer who are assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

Numerator – the number of people in the denominator who are assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

Denominator – the number of people with lung cancer.

What the quality statement means for each audience

Service providers ensure there are systems in place for people with lung cancer to be assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

Clinical oncologists specialising in thoracic oncology assess people with lung cancer for radiotherapy with curative intent.

Commissioners ensure they commission services for people with lung cancer to be assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

People with lung cancer are assessed by a specialist in cancers of the chest (a clinical oncologist specialising in thoracic oncology) to see if radiotherapy to try and cure the cancer would be suitable for them.

Source guidance

Lung cancer: diagnosis and management (2019) NICE guideline NG122, recommendation 1.4.19

Data source

Structure: Local data collection.

Process: Local data collection.